Therapeutic Hotline: Letter
Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy
L. Martínez Leboráns,
Corresponding Author
L. Martínez Leboráns
Departments of Dermatology
Address correspondence and reprint requests to: Lorena Martínez Leboráns, MD, Avd. Tres Cruces, 2, Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia,46014 Valencia, Spain, or email:
[email protected].
Search for more papers by this author A. Esteve Martínez,
A. Esteve Martínez
Departments of Dermatology
Search for more papers by this author A. M. Victoria Martínez,
A. M. Victoria Martínez
Departments of Dermatology
Search for more papers by this author V. Alegre de Miquel,
V. Alegre de Miquel
Departments of Dermatology
Search for more papers by this author A. Berrocal Jaime,
A. Berrocal Jaime
Oncology, Valencia University General Hospital, Valencia, Spain
Search for more papers by this author
L. Martínez Leboráns,
Corresponding Author
L. Martínez Leboráns
Departments of Dermatology
Address correspondence and reprint requests to: Lorena Martínez Leboráns, MD, Avd. Tres Cruces, 2, Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia,46014 Valencia, Spain, or email:
[email protected].
Search for more papers by this author A. Esteve Martínez,
A. Esteve Martínez
Departments of Dermatology
Search for more papers by this author A. M. Victoria Martínez,
A. M. Victoria Martínez
Departments of Dermatology
Search for more papers by this author V. Alegre de Miquel,
V. Alegre de Miquel
Departments of Dermatology
Search for more papers by this author A. Berrocal Jaime,
A. Berrocal Jaime
Oncology, Valencia University General Hospital, Valencia, Spain
Search for more papers by this author
First published: 30 June 2016
No abstract is available for this article.
References
- 1
Hodi FS,
O'Day SJ,
McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010: 363 (8): 711–723.
- 2
Bertrand A,
Kostine M,
Barnetche T,
Truchetet ME,
Schaeverbeke T. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med 2015: 4 (13): 211.
- 3
Beutler BD,
Cohen PR. Sarcoidosis in melanoma patients: case report and literature review. Cancers (Basel). 2015: 7 (2): 1005–1021
- 4
Iannuzzi M,
Fontana J. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011: 305: 391–399
- 5
Reule RB,
North JP. Cutaneous and pulmonary sarcoidosis-like reaction associated with ipilimumab. J Am Acad Dermatol 2013: 69: e272–273
- 6
Eckert A,
Schoeffler A,
Dalle S,
Phan A,
Kiakouama L,
Thomas L. Anti-CTLA4 monoclonal antibody induced sarcoidosis in a metastatic melanoma patient. Dermatology 2009: 218: 69–70.
- 7
Tissot C,
Carsin A,
Freymond N,
Pacheco Y,
Devouassoux G. Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapy. Eur Respir J 2013: 41: 246–247.
